Notice Number: NOT-HL-19-690
Release Date: April 16, 2019
National Heart, Lung, and Blood Institute (NHLBI)
The purpose of this Notice is to define the types of investigator-initiated clinical trial applications that may be submitted to NHLBI in response to the NIH Research Project Grant (Parent R01 Clinical Trial Required) FOA.
NHLBI will accept applications in response to the NIH Parent (R01 Clinical Trial Required) FOA that propose:
The following types of clinical trials are not allowed and will not be accepted by NHLBI under the NIH Research Project Grant (Parent R01 Clinical Trial Required) FOA:
Applicants are strongly encouraged to consult the NHLBI Scientific/Research Contact listed on the NIH Research Project Grant (Parent R01 Clinical Trial Required) FOA prior to submission to confirm the NHLBI-specific clinical trial FOA to which the application should be submitted.
Applicants are also encouraged to refer to the NHLBI Clinical Trial Funding Opportunities webpage.
Please direct all inquiries to:
W. Keith Hoots, MD, Director
Division of Blood Diseases and Resources
Katie Kavounis, MPH,Clinical Trials Specialist
Division of Cardiovascular Sciences
Office of Clinical Research
James P. Kiley, Ph.D., Director
Division of Lung Diseases
George A. Mensah, MD, FACC, Director
Center for Translation Research and Implementation Science (CTRIS)